Wenxin Keli Ingredients

Formula, names, and evidence boundaries

The approved baseline names five components associated with a Wenxin Keli formula. This page preserves that observation while making clear that the exact identity, plant material, proportions, preparation, and quality of the product in a reader’s hands require primary label or manufacturer verification.

Ingredient list observed in the baseline

The baseline names the following five components:

  • Radix Codonopsis, also written as Codonopsis in research descriptions
  • Rhizoma Polygonati, described as Polygonatum rhizome in some literature
  • Panax notoginseng
  • amber
  • spikenard, also described as Nardostachys in some literature

This is an observed list from the approved baseline, not an independent certification of the exact product currently sold or used. Botanical naming and translation can vary across labels and papers.

Names and identity

A common name, transliteration, or translated ingredient name may not identify the exact species, plant part, mineral material, extract ratio, preparation method, or amount. Confirm those details from the complete label and, where needed, a primary manufacturer or regulatory record.

Do not treat a five-item list as proof that two products have identical composition. Product identity, manufacturing controls, legal status, and clinical evidence are separate questions.

Traditional context

Ingredient names can be presented in the context of traditional Chinese medicine, but traditional terminology does not establish a modern clinical outcome. A traditional description also does not establish that an isolated ingredient reproduces the effects of a multi-ingredient formula.

Research and traditional context should therefore remain separate. This page does not convert traditional descriptions into treatment claims.

What research can and cannot show

A randomized trial described a specified Wenxin Keli preparation containing five main components and studied that preparation in a defined human population. The result belongs to the studied formula, population, duration, and outcomes; it does not show that any one ingredient independently produces the same result.

Ingredient-level, laboratory, and animal findings require their own source, model, comparator, outcome, and limitation. This page does not summarize such a finding without those details. Review the study-type guide.

Verification and safety limits

Before relying on a product description, compare the exact label, ingredient list, manufacturer or importer, lot or batch information, expiry date, packaging, and seller. Do not infer safety or suitability from a familiar name, a low price, or the presence of a single ingredient.

For possible interactions, special populations, product-quality concerns, or new symptoms, read the safety guide and discuss the exact product with a qualified healthcare professional. This page does not provide an individualized dose.

Sources and evidence limits

Last evidence review: August 20, 2026. The five-item list remains pending primary label verification; source inclusion is not an endorsement or treatment recommendation.